Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases

ANIKET S. Rali, SAGAR RANKA, JEREMY A. MAZUREK, MARSHALL D. BRINKLEY, A. R.I. CEDARS, DANIEL CLARK, N. H.U.E. DO, GINA E. LAZZARA, L. Y.N.N. PUNNOOSE, EMILY SANDHAUS, ASHISH SHAH, S. I.V.A. TADURU, M. A.R.K. WIGGER, SANDIP ZALAWADIYA, JOSEPH ROGERS, JOANN LINDENFELD, KELLY SCHLENDORF, JONATHAN N. MENACHEM

Research output: Contribution to journalArticlepeer-review

Abstract

Adults with congenital heart diseases may not be candidates for conventional therapies to control ventricular systolic dysfunction, including mechanical circulatory support, which moves potential heart-transplantation recipients to a listing status of higher priority. This results in longer waitlist times and greater mortality rates. Exception-status listing allows a pathway for this complex and anatomically heterogenous group of patients to be listed for heart transplantation at appropriately high listing status. Our study queried the United Network for Organ Sharing registry to evaluate trends in the use of exception-status listing among adults with congenital heart diseases awaiting heart transplantation. Uptrend in the use of exception-status listing precedes the new allocation system, but it has been greatest since changes were made in the allocation system. It continues to remain a vital pathway for adults with congenital heart disease (whose waitlist mortality rates are often not characterized adequately by using the waitlist-status criteria) timely access to heart transplantation.

Original languageEnglish (US)
Pages (from-to)415-421
Number of pages7
JournalJournal of cardiac failure
Volume28
Issue number3
DOIs
StatePublished - Mar 2022

Keywords

  • Heart transplantation allocation system
  • adults with congenital heart disease
  • exception-status listing
  • heart transplantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases'. Together they form a unique fingerprint.

Cite this